Interactions of glutamate receptor agonists with long-term potentiation in the rat hippocampal slice

• Published in: European journal of pharmacology 2000-06, Vol.398 (3), p.349-359
• Main Authors: Youssef, F, Stone, T.W, Addae, J.I
• Format: Article
• Language: English
• Subjects: Action Potentials - drug effects; Action Potentials - physiology; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacology; Animals; Biological and medical sciences; Excitatory Amino Acid Agonists - pharmacology; Excitatory Postsynaptic Potentials - drug effects; Excitatory Postsynaptic Potentials - physiology; Glutamatergic system (aspartate and other excitatory aminoacids); Hippocampus; Hippocampus - drug effects; Hippocampus - physiology; Kynurenine; Long-term potentiation; Long-Term Potentiation - drug effects; Long-Term Potentiation - physiology; Male; Medical sciences; N-Methylaspartate - pharmacology; Neuropharmacology; Neurotransmitters. Neurotransmission. Receptors; NMDA ( N-methyl- d-aspartate); NMDA receptor subunit; Pharmacology. Drug treatments; Quinolinic acid; Quinolinic Acid - pharmacology; Rats; Rats, Sprague-Dawley; Rats, Wistar
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/S0014-2999(00)00257-0

Previous work has described the apparent desensitisation of neuronal networks in the rat neocortex to amino acid agonists, following prior exposure several minutes earlier. Since long-term potentiation is believed to involve activation of amino acid receptors, we have now sought to determine whether long-term potentiation can modify the sensitivity of neurones to glutamate receptor agonists in rat hippocampal slices. Responses were measured as the change in population spike or postsynaptic potential (e.p.s.p.) size. Two applications of N-methyl- d-aspartate (NMDA), quinolinic acid, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) or kainate, 45 min apart, did not exhibit any apparent desensitisation. However, the induction of long-term potentiation produced a marked loss of sensitivity to quinolinic acid, with smaller effects on NMDA, AMPA and kainate responses. No marked changes were obtained of e.p.s.p. size. In order to localise the cellular sites of these changes, agonists were also applied by microiontophoresis to the cell bodies or dendritic regions of CA1 neurones. Responses to quinolinic acid showed apparent desensitisation at both sites, whereas no decrease was observed in responses to NMDA or AMPA application. The induction of long-term potentiation again produced a decrease in the size of responses to NMDA and AMPA. Inhibition of nitric oxide (NO) synthase prevented the long-term potentiation-induced loss of responsiveness to NMDA, but not AMPA, implying a role for NO in the loss of NMDA sensitivity. Recordings of single cell activity during the iontophoretic application of agonists and induction of long-term potentiation showed that responses to NMDA were often suppressed to a greater extent than to quinolinic acid. The results indicate that long-term potentiation can modify the sensitivity of hippocampal neurones to glutamate receptor agonists, and that differences exist in the pharmacology of NMDA and quinolinic acid.